Latest & greatest articles for depression

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on depression or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on depression and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for depression

1. Harmonized Outcome Measures for Use in Depression Patient Registries and Clinical Practice. (Abstract)

Harmonized Outcome Measures for Use in Depression Patient Registries and Clinical Practice. Major depressive disorder is a common mental health condition that affects an estimated 16.2 million adults and 3.1 million adolescents in the United States. Yet, a lack of uniformity remains in measurements and monitoring for depression both in clinical practice and in research settings. This project aimed to develop a minimum set of standardized outcome measures relevant to both patients and clinicians (...) that can be collected in depression registries and clinical practice. Twenty-nine depression registries and related data collection efforts were identified and invited to submit outcome measures. Additional measures were identified through literature searches and reviews of quality measures. A multistakeholder panel representing clinicians; payers; government agencies; industry; and medical specialty, health care quality, and patient advocacy organizations categorized the 27 identified measures using

2020 Annals of Internal Medicine

2. Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis. (Abstract)

Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis. The Patient Health Questionnaire depression module (PHQ-9) is a 9-item self-administered instrument used for detecting depression and assessing severity of depression. The Patient Health Questionnaire-2 (PHQ-2) consists of the first 2 items of the PHQ-9 (which assess the frequency of depressed mood and anhedonia) and can be used as a first step to identify (...) patients for evaluation with the full PHQ-9.To estimate PHQ-2 accuracy alone and combined with the PHQ-9 for detecting major depression.MEDLINE, MEDLINE In-Process & Other Non-Indexed Citations, PsycINFO, and Web of Science (January 2000-May 2018).Eligible data sets compared PHQ-2 scores with major depression diagnoses from a validated diagnostic interview.Individual participant data were synthesized with bivariate random-effects meta-analysis to estimate pooled sensitivity and specificity of the PHQ-2

2020 JAMA

3. Cognitive training interventions and depression in mild cognitive impairment and dementia: a systematic review and meta-analysis of randomized controlled trials

Cognitive training interventions and depression in mild cognitive impairment and dementia: a systematic review and meta-analysis of randomized controlled trials Cognitive Training Interventions and Depression in Mild Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Age Ageing Actions . 2020 May 6;afaa063. doi: 10.1093/ageing/afaa063. Online ahead of print. Cognitive Training Interventions and Depression in Mild Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , , , , , Affiliations Expand Affiliations 1 Department

2020 EvidenceUpdates

4. Effect of Adding a Work-Focused Intervention to Integrated Care for Depression in the Veterans Health Administration: A Randomized Clinical Trial Full Text available with Trip Pro

Effect of Adding a Work-Focused Intervention to Integrated Care for Depression in the Veterans Health Administration: A Randomized Clinical Trial Effect of Adding a Work-Focused Intervention to Integrated Care for Depression in the Veterans Health Administration: A Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily (...) Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation JAMA Netw Open Actions . 2020 Feb 5;3(2):e200075. doi: 10.1001/jamanetworkopen.2020.0075. Effect of Adding a Work-Focused Intervention to Integrated Care for Depression in the Veterans Health Administration: A Randomized Clinical Trial , , , , Affiliations Expand Affiliations 1 Program on Health, Work and Productivity, Institute for Clinical

2020 EvidenceUpdates

5. Space from Depression for treating adults with depression

Space from Depression for treating adults with depression Space from Depression for treating adults with depression Medtech innovation briefing Published: 7 May 2020 www.nice.org.uk/guidance/mib215 pathways Expert panel conclusions Expert panel conclusions • Therapist and Improving Access to Psychological Therapies (IAPT) service feedback on Space from Depression (SilverCloud) was generally positive. The evaluation data and user feedback showed that it was an effective treatment for some users (...) . • The IAPT expert panel therefore concluded that the case for adoption is partially supported case for adoption is partially supported for Space from Depression. They noted that Space from Depression is suitable for use in IAPT services when: - there is monitoring to identify and help people who stop engaging with the service - there is flexibility about how much the therapist and service user can communicate - there are clear plans to help service providers put Space from Depression into practice. Panel

2020 National Institute for Health and Clinical Excellence - Advice

6. Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients: A Randomized Clinical Trial

Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients: A Randomized Clinical Trial Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients: A Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes (...) Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation JAMA Psychiatry Actions . 2020 May 20;e201011. doi: 10.1001/jamapsychiatry.2020.1011. Online ahead of print. Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients: A Randomized Clinical Trial , , , , , , Affiliations Expand Affiliations 1 Center for Behavioral Intervention Technologies, Northwestern University, Chicago, Illinois

2020 EvidenceUpdates

7. Standardized Library of Depression Outcome Measures

Standardized Library of Depression Outcome Measures Research White Paper Standardized Library of Depression Outcome MeasuresResearch White Paper Standardized Library of Depression Outcome Measures Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2014-00004-C Prepared by: L&M Policy Research, LLC Washington, DC 20009 With partners: OM1, AcademyHealth Investigators: Richard E (...) language for acknowledgment: This work was based on an evidence report, [INSERT TITLE], by the Evidence-based Practice Center Program at the Agency for Healthcare Research and Quality (AHRQ). Suggested citation: Gliklich RE, Leavy MB, Li F. Standardized Library of Depression Outcome Measures. Research White Paper. (Prepared by L&M Policy Research, LLC under Contract No. 290-2014-00004-C.) AHRQ Publication No. 19(20)-EHC005. Rockville, MD: Agency for Healthcare Research and Quality; May 2020. Posted

2020 Effective Health Care Program (AHRQ)

8. Telephone-based nurse-delivered interpersonal psychotherapy for postpartum depression: nationwide randomised controlled trial Full Text available with Trip Pro

Telephone-based nurse-delivered interpersonal psychotherapy for postpartum depression: nationwide randomised controlled trial Telephone-based Nurse-Delivered Interpersonal Psychotherapy for Postpartum Depression: Nationwide Randomised Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health (...) Permalink Copy Page navigation Br J Psychiatry Actions . 2020 Apr;216(4):189-196. doi: 10.1192/bjp.2019.275. Telephone-based Nurse-Delivered Interpersonal Psychotherapy for Postpartum Depression: Nationwide Randomised Controlled Trial , , , , Affiliations Expand Affiliations 1 Professor, Lawrence S. Bloomberg Faculty of Nursing, University of Toronto; Women's Health Research Chair, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Canada. 2 Associate Professor of Psychiatry, Department

2020 EvidenceUpdates

9. Treatment of Depression in Children and Adolescents

Treatment of Depression in Children and Adolescents Treatment of Depression in Children and Adolescents: A Systematic Review Comparative Effectiveness Review Number 224 R Comparative Effectiveness Review Number 224 Treatment of Depression in Children and Adolescents: A Systematic Review Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00011-I Prepared by: RTI (...) and harms of pharmacological and nonpharmacological treatments for child and adolescent depressive disorders. Key Messages • Cognitive behavioral therapy (CBT), fluoxetine, escitalopram, and combined fluoxetine plus CBT may reduce depressive symptoms in the short term; clinical significance is unclear. • CBT may improve symptoms and functional status. CBT plus medications may help prevent relapse. • Selective serotonin reuptake inhibitors (SSRIs) as a class may improve response and functional status

2020 Effective Health Care Program (AHRQ)

10. Depression: Perinatal

Depression: Perinatal © 2018 Kaiser Foundation Health Plan of Washington. All rights reserved. 1 Perinatal Depression Screening, Diagnosis, and Treatment Guideline Major Changes as of December 2018 2 Target Population 2 Behavioral Health Integration/Maternal Behavioral Health 2 Screening and Diagnosis 3 Treatment Overview of options 5 Shared decision making: pregnant women 7 Key points: breastfeeding women 7 Pharmacologic options 8 Follow-up 10 Evidence Summary 11 References 12 Guideline (...) antidepressant in pregnancy. The first-line antidepressant in both pregnancy and lactation is sertraline and second-line is escitalopram. Fluoxetine is not recommended. Previously, sertraline was first-line and citalopram and fluoxetine were second-line antidepressants for pregnancy and lactation. Escitalopram was not on the preferred list. For pregnant and postpartum women, we now recommend using the Maternal Behavioral Health Screening tool. Previously, depression screening for all adults was done

2020 Kaiser Permanente Clinical Guidelines

11. Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression

Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Stay at home Only go outside for food, health reasons (...) or work (but only if you cannot work from home) If you go out, stay 2 metres (6ft) away from other people at all times Wash your hands as soon as you get home Do not meet others, even friends or family. You can spread the virus even if you don’t have symptoms. Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression Benzodiazepines and opioids can both cause respiratory depression, which can be fatal if not recognised in time. Only prescribe together

2020 MHRA Drug Safety Update

12. Vagal nerve stimulation for epilepsy and depression

Vagal nerve stimulation for epilepsy and depression Vagal nerve stimulation for epilepsy and depression | Washington State Health Care Authority Toggle search Toggle navigation Announcement Menu Apple Health Eligibility Manual Search Close menu Search form Search all of HCA Search Health care services and supports Search Billers, providers, & partners Search Employee & retiree benefits Search About HCA Search Vagal nerve stimulation for epilepsy and depression Vagal nerve stimulation (...) for epilepsy and depression Public comment period extended. Public comment on the vagal nerve stimulation draft report has been extended until close of business, March 30, 2020. Submit all comments to: Vagal nerve stimulation (VNS) for epilepsy and depression was first reviewed by the HTA in 2009. In 2013, a review of VNS medical literature was conducted to determine if newly available evidence published since 2008 was likely to change the original coverage determination. The technology was not selected

2020 Washington Health Care Authority

13. End-stage Renal Disease and Depression: A Systematic Review

End-stage Renal Disease and Depression: A Systematic Review Management Briefs eBrief-no169 -- End-stage Renal Disease and Depression: A Systematic Review Talk to the Veterans Crisis Line now An official website of the United States government Here's how you know The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. The https:// ensures that you're connecting (...) to the official website and that any information you provide is encrypted and sent securely. Search Search the ORD website Button to search HSRD Contact us TTY: 711 × We're here anytime, day or night — 24/7 If you are a Veteran in crisis or concerned about one, connect with our caring, qualified responders for confidential help. Many of them are Veterans themselves. Get more resources at . » » » Management Briefs eBrief-no169 -- End-stage Renal Disease and Depression: A Systematic Review Health Services

2020 Veterans Affairs - R&D

14. But I am not Depressed: Antidepressants for Irritable Bowel Syndrome

But I am not Depressed: Antidepressants for Irritable Bowel Syndrome Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research. www.acfp.ca (...) January 20, 2020 But I am not Depressed: Antidepressants for Irritable Bowel Syndrome Clinical Question: Do antidepressant medications improve irritable bowel syndrome (IBS) symptoms? Bottom Line: Both tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) may improve overall IBS symptoms. About 55% of patients treated with TCAs or SSRIs will benefit compared to ~35% with placebo. Only TCAs improve abdominal pain for ~60% of patients compared to ~30% with placebo. TCA

2020 Tools for Practice

15. Mental Health: Targeted School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms

Mental Health: Targeted School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms Mental Health: Targeted School-Based CBT | The Community Guide Welcome to The Community Guide! Let us know what you think of the website by completing this . Open Navigation or Search form Search Search The Community Guide You are here » Systematic Review Topic Recommended (strong evidence) February 2019 Audience Adolescents and Young Adults Children/Infants Setting School (...) Strategy Counseling Health Education Mental Health: Targeted School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms Tabs Snapshot Summary of CPSTF Finding The targeted school-based cognitive behavioral therapy programs to reduce depression and anxiety symptoms among school-aged children and adolescents who are assessed to be at increased risk for these conditions. The CPSTF also recommends , and and CBT to reduce psychological harm from traumatic events among

2020 Community Preventive Services Task Force

16. Mental Health: Universal School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms

Mental Health: Universal School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms Mental Health: Universal School-Based CBT | The Community Guide Welcome to The Community Guide! Let us know what you think of the website by completing this . Open Navigation or Search form Search Search The Community Guide You are here » Systematic Review Topic Recommended (strong evidence) February 2019 Audience Adolescents and Young Adults Children/Infants Setting School (...) Strategy Counseling Health Education Mental Health: Universal School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms Tabs Snapshot Summary of CPSTF Finding The universal school-based cognitive behavioral therapy programs to prevent or reduce depression and anxiety symptoms among school-aged children and adolescents. The CPSTF also recommends for students who are assessed to be at increased risk for these conditions, and and CBT to reduce psychological harm from

2020 Community Preventive Services Task Force

17. Depression and post-traumatic stress during major social unrest in Hong Kong: a 10-year prospective cohort study. (Abstract)

Depression and post-traumatic stress during major social unrest in Hong Kong: a 10-year prospective cohort study. Hong Kong has been embroiled in increasingly violent social unrest since June, 2019. We examined the associated population mental health burden, risk factors, and health-care needs.In a population-based prospective cohort, adult participants aged 18 years or older were assessed at nine timepoints from 2009. Probable depression was measured using the Patient Health Questionnaire-9 (...) (score ≥10) and suspected post-traumatic stress disorder (PTSD) by the PTSD Checklist-Civilian Version (score ≥14), plus direct exposure to traumatic events related to the ongoing social unrest. We used multivariable logistic regression to identify factors associated with both outcomes, adjusting for doctor-diagnosed depression or anxiety disorders before the unrest. On the basis of routine service statistics and respondents' intention to seek professional care, we projected the number of additional

2020 Lancet

18. Esketamine (Spravato) - major depression

Esketamine (Spravato) - major depression Official address Domenico Scarlattilaan 6 ? 1083 HS Amsterdam ? The Netherlands An agency of the European Union Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 © European Medicines Agency, 2019. Reproduction is authorised provided the source is acknowledged. EMA/578240/2019 EMEA/H/C/004535 Spravato (esketamine) An overview of Spravato and why (...) it is authorised in the EU What is Spravato and what is it used for? Spravato is a medicine used to treat adults with major depression that is resistant to treatment. It is used in combination with an SSRI or SNRI medicine (other antidepressants) when at least two other treatments have failed. Spravato contains the active substance esketamine. How is Spravato used? Spravato is available as a nasal spray to be used by the patient in a clinic or doctor’s office, under the direct supervision of a healthcare

2020 European Medicines Agency - EPARs

19. Effectiveness of an Interventional Package on the Level of Anxiety, Depression, and Fatigue among Patients with Cervical Cancer. Full Text available with Trip Pro

Effectiveness of an Interventional Package on the Level of Anxiety, Depression, and Fatigue among Patients with Cervical Cancer. To evaluate the effectiveness of interventional package on the level of anxiety, depression, and fatigue.The study was conducted in room no. 5, first floor, B Block, Department of Radiotherapy, Nehru Hospital, Postgraduate Institute of Medical Education and Research, Chandigarh Quasi experimental pretest-posttest design was used in the study. A total of 60 patients (...) receiving radiotherapy/chemotherapy were assigned in two groups of 30 each, through total enumeration sampling technique. The tools used for the study were Zung Anxiety Scale, Beck Depression inventory, and Fatigue Scale. The protocol used for the study includes the Jacobson's Progressive muscle relaxtion technique, counsling and home care techniques.Sociodemographic variables and clinical profile of participants in both groups were comparable. Interventional package significantly reduces the anxiety

2019 Asia-Pacific journal of oncology nursing Controlled trial quality: uncertain

20. The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States: A Decision Analytic Model. (Abstract)

The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States: A Decision Analytic Model. Most guidelines for major depressive disorder recommend initial treatment with either a second-generation antidepressant (SGA) or cognitive behavioral therapy (CBT). Although most trials suggest that these treatments have similar efficacy, their health economic implications are uncertain.To quantify (...) the cost-effectiveness of CBT versus SGA for initial treatment of depression.Decision analytic model.Relative effectiveness data from a meta-analysis of randomized controlled trials; additional clinical and economic data from other publications.Adults with newly diagnosed major depressive disorder in the United States.1 to 5 years.Health care sector and societal.Initial treatment with either an SGA or group and individual CBT.Costs in 2014 U.S. dollars, quality-adjusted life-years (QALYs

2019 Annals of Internal Medicine